Autopsy report · NCT04904718

Real World Evaluation of Advisor Pro in Clinical Practice

“Decided not to proceed with enrollment - study never started”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Yale University

Sponsor type

University, hospital or other

Conditions

Type1diabetes

Interventions

DreaMed Advisor Pro

Participants

0

Trials that died the same way

• A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis
  “Study did not start enrollment due to business reasons” (81% match in meaning)
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)
  “Study halted prematurely, prior to enrollment of first participant” (80% match in meaning)
• Adenomyosis: Genomic Mechanisms and Biological Response
  “The study never got funded so never started enrolling” (79% match in meaning)
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (78% match in meaning)
• Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study
  “Study not started, no longer required” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.